Loading…
← Back to schedule
Panel: Cell & Gene Therapy: Challenges, Trends and Technologies
Wednesday January 15, 2025 2:40pm - 3:20pm PST
Hyatt Regency San Francisco
With advancements in platform technologies and automation, the cell and gene therapy space is poised for changes. During this panel discussion, industry leaders will explore challenges and share insights on navigating regulatory hurdles, optimizing manufacturing and leveraging emerging technologies to address broader disease states.
Moderators
avatar for Fraiser Kansteiner

Fraiser Kansteiner

Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser... Read More →
Speakers
avatar for Christopher Arendt, Ph.D.

Christopher Arendt, Ph.D.

Chief Scientific Officer, Head of Research, Takeda
Based at Takeda’s Cambridge, Massachusetts, R&D campus, Christopher Arendt is responsible for oversight of Takeda’s Research and Early Development portfolio across Takeda’s core therapeutic areas of Gastroenterology andInflammation, Oncology, and Neuroscience.  Prior to his... Read More →
avatar for Dr. Nadir Mahmood

Dr. Nadir Mahmood

President, Nkarta
Dr. Nadir Mahmood serves as President of Nkarta, where he is responsible for driving the company’s strategic focus, business excellence, and technical success. He previously served as the Chief Executive Officer of Rezo Therapeutics, a private-stage drug discovery company. Prior... Read More →
avatar for Cindy Perettie

Cindy Perettie

Executive Vice President, Kite, a Gilead Company
Cindy Perettie serves as Executive Vice President of Kite, a Gilead Company, and is responsible for overseeing the cell therapy business. Cindy joined Kite in 2023 with more than 20 years of scientific and commercial leadership experience in global biopharmaceutical organizations... Read More →
avatar for Shehnaaz Suliman, M.D., MBA, M.Phil.

Shehnaaz Suliman, M.D., MBA, M.Phil.

Chief Executive Officer, ReCode Therapeutics
Shehnaaz Suliman, M.D., MBA, M.Phil., serves as Chief Executive Officer of ReCode Therapeutics, a leading privately held biotechnology company powering the future of genetic medicines with a next-generation lipid nanoparticle platform. Lead programs are in primary ciliary dyskinesia... Read More →
avatar for Richard Wilson

Richard Wilson

SVP, Primary Focus Lead Genetic Regulation, Astellas
Richard Wilson, Senior Vice President, Primary Focus Lead of Genetic Regulation at Astellas Gene Therapies, is responsible for setting and leading the gene therapy strategy for Astellas’ Primary Focus Genetic Regulation. Richard joined Astellas Gene Therapies (formerly Audentes... Read More →
Wednesday January 15, 2025 2:40pm - 3:20pm PST
Hyatt Regency San Francisco
  Panel
  • Qtag Featured

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Share Modal

Share this link via

Or copy link